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Patient’s perception of recovery after
osteotome-mediated sinus floor elevation
with Bio-Oss collagen compared with no
grafting material: a randomized single-
blinded controlled trial
Thomas Starch-Jensen1,2* and Niels Henrik Bruun3
Abstract
Background: Osteotome-mediated sinus floor elevation with or without a grafting material is associated with high
implant survival, intrasinus bone gain, and low frequency of complications. However, patient’s perception of
recovery and satisfaction with the surgical intervention are rarely reported. The objective of the present randomized
controlled trial was to assess patient’s perception of recovery after osteotome-mediated sinus floor elevation with
Bio-Oss collagen compared with no grafting material. Forty healthy patients were randomly allocated to Bio-Oss
collagen or no grafting material. Oral health-related quality of life was assessed by Oral Health Impact Profile-14 at
enrollment. Patient’s perception of recovery was assessed by self-administrated questionnaires and visual analog
scale evaluating pain, social and working isolation, physical appearance, duration and quality of life alterations,
eating and speaking ability, diet variations, and sleep impairment after 1 week and 1 month, respectively.
Descriptive statistics was expressed as mean percentage with standard deviation. Correlation between impaired oral
health-related quality of life, age, gender, and recovery were assessed by T test. Level of significance was 0.05.
Results: Osteotome-mediated sinus floor elevation is associated with high patient satisfaction, limited postoperative
discomfort, and willingness to undergo similar surgery. Influence on patient’s daily life activities seems to be
minimal and limited to the first postoperative days. Most patients managed to return to work and their routine
daily activities after 0-2 days. Impaired preoperative oral health-related quality of life, gender, or younger age seems
not to predispose for delayed recovery. However, number of days with pain, eating difficulties, and sleep
disturbances were significantly increased with Bio-Oss collagen compared with no grafting material (P<0.05).
Conclusion: Patient’s discomfort seems to be minimal and limited to the first postoperative days following
osteotome-mediated sinus floor elevation with or without a grafting material. Impaired preoperative oral health-
related quality of life, gender, or younger age seems not to predispose for delayed recovery.
Keywords: Alveolar ridge augmentation, Dental implants, Health care surveys, Maxilla, Quality of life, Sinus floor
augmentation
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Introduction
Osteotome-mediated sinus floor elevation (OMSFE) with
or without a grafting material have demonstrated high im-
plant survival, intrasinus bone gain, limited peri-implant
marginal bone loss, and low frequency of complications,
as documented in systematic reviews and meta-analyses
[1–5]. Implant survival rate and percentage of peri-
implant marginal bone loss are commonly used to define
a successful implant treatment outcome. However, clinical
parameters do not necessarily reflect patient’s expectations
and satisfaction with the surgical intervention or the
implant-supported restoration. Therefore, success of im-
plant treatment should not only focus on objective criteria
but also include patient’s perception of recovery and
patient-reported outcome measures (PROM), which is in
agreement with a newly published systematic review and
ITI consensus report concluding that there is an urgent
need for standardized reporting of PROM in the field of
implant dentistry [6, 7].
Prosthetic rehabilitation of partial or totally edentulous pa-
tients with implants significantly improves oral health-related
quality of life (OHRQL) [8]. Self-administered questionnaire
has demonstrated high patient satisfaction, low patient dis-
comfort, and willingness to undergo the same type of surgery
after OMSFE with simultaneous implant placement [9–12].
However, patient’s perception of recovery and PROM are in-
fluenced by various factors, such as gender, age, OHRQL,
psychosocial factors, the surgical intervention, post-surgical
morbidity, and complications [13, 14]. Nevertheless, assess-
ment of predisposing factors as well as relationship between
OHRQL and patient’s perception of recovery using validated
self-administrated questionnaires after OMSFE with simul-
taneous implant placement have never previously been con-
ducted. Therefore, the objective of the present randomized
controlled trial was to test the hypothesis of no difference in
patient’s perception of recovery after OMSFE with Bio-Oss
collagen compared with no grafting material using validated
self-administrated questionnaires.
Material and methods
The protocol was prepared in full accordance with
guidelines for reporting randomized controlled studies
(CONSORT) (http://www.consort-statement.org/). The
study was approved by The North Denmark Region
Committee on Health Research Ethics (Approval No: N-
20180027). Patients were recruited by public invitation
through Facebook or admitted to the Department of
Oral and Maxillofacial Surgery, Aalborg University Hos-
pital, Denmark, for implant placement in the posterior
part of the maxilla. Candidates were screened for inclu-
sion and exclusion criteria at enrollment (Table 1). The
residual bone height in the posterior maxilla was esti-
mated by cone beam computed tomography at enroll-
ment. Included patients received written as well as
verbal information about the study protocol and signed
an informed consent form before initiating the study.
OMSFE and implant placement was free for the patients,
but they had to pay for the prosthetic solution them-
selves. A total of 40 patients with a missing posterior
maxillary tooth were included and randomly allocated to
(1) OMSFE with Bio-Oss collagen and simultaneous im-
plant placement or (2) OMSFE with no grafting material
and simultaneous implant placement. A computer-aided
block randomization was used to allocate included pa-
tients into two groups of same size. Based on sample size
calculation and assuming a 10% dropout rate, it was
planned to enroll 20 patients for each treatment group,
in order to detect a 15% difference between the two
groups in long-term implant survival, with a power of
0.8 and a significance level equal to 0.05.
Surgical procedure
One hour prior to OMSFE, all patients were pre-
medicated with analgesics involving 400 mg ibuprofen
(Burana, Teva, Denmark) and 1000 mg paracetamol
(Pamol, Takeda Pharma A/S, Denmark) and prophylac-
tic antibiotic therapy including 2 g amoxicillin (Imadrax,
Sandoz, Denmark) or clindamycin 600mg (Dalacin,
Alternova, Denmark) if allergic to penicillin. All patients
rinsed with 0.12% chlorhexidine solution for 1 min im-
mediately before surgery. The surgical procedures were
performed by the same trained surgeon (TSJ) in local
anesthesia using lidocaine (2%) with 1:200,000 adren-
aline (Xylocaine, Amgros I/S, Denmark). An intraoral
marginal incision was performed at the implant site con-
tinuing into the gingival sulcus of the adjacent teeth.
Table 1 Inclusion and exclusion criteria
Inclusion criteria
• >20 years
• Missing one posterior maxillary tooth for more than four months
• Residual alveolar bone height of the maxillary alveolar ridge ≥6 mm
and ≤10 mm
• Width of the alveolar ridge ≥6.5 mm
• Mandibular occluding teeth
• Able to understand and sign the informed consent
• Single tooth gaps as well as free ended prosthetic solutions
Exclusion criteria
• Contraindications to implant therapy
• Full mouth plaque score >25%
• Progressive marginal periodontitis
• Acute infection in the area intended for implant placement
• Parafunction, bruxism, or clenching
• Psychiatric problems or unrealistic expectations
• Heavy tobacco use define as >10 cigarettes per day
• Current pregnancy at the time of recruitment
• Physical handicaps that would interfere with the ability to perform
adequate oral hygiene
• Inability or unwillingness to regularly attend the scheduled follow-
up visits
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Mucoperiosteum was reflected exposing the alveolar
process. An implant bed was successively prepared on
the top of the alveolar crest according to the manufac-
turer’s drilling protocol. The depth of the drilling was
ended at least 2 mm from the bottom of the maxillary
sinus floor. The Schneiderian membrane including the
original maxillary sinus floor was elevated to the planned
implant length using calibrated osteotomes combined
with piezosurgery and hydraulic pressure technique
(Sinus physiolift II, Mectron, Carasco, Italy). A water-
tight adaptor with a tube was inserted in the prepared
implant bed and connected to a syringe containing 2 ml
of physiological saline solution (Fig. 1). The Schneiderian
membrane was safely elevated by controlling the pres-
sure of the liquid by means of the attached physiolifter
device. The integrity of the Schneiderian membrane was
checked by Valsalva maneuver and patients were asked,
whether they had sensation of water in the nose or
throat during use of the hydraulic technique. Moreover,
the implant site was probed with the implant depth gage
to feel the presence of an intact Schneiderian membrane.
If the Schneiderian membrane was largely perforated
with communication to the maxillary sinus, the patient
was withdrawn from the study. A sealed randomization
envelope was opened in order to allocate patients to (1)
OMSFE with Bio-Oss collagen 250 mg (0.4–0.5 cm3,
Geistlich Pharma AG, Wolhusen, Switzerland) and
simultaneous implant placement (control group) or (2)
OMSFE with no grafting material and simultaneous im-
plant placement (test group). In the control group, the
Bio-Oss collagen sponge was soaked in saline and
pushed through each implant site underneath the
Schneiderian membrane. A straight 13 mm implant
(ASTRA TECH Implant System EV, diameter 3.6, 4.2
or 4.8, Dentsply Sirona Implants, Mölndal, Sweden)
was inserted with a cover screw. Periosteum and mu-
cosa were sutured with Vicryl 4-0 (Ethicon FS-2, Ethi-
con, St-Stevens-Woluwe, Belgium). No provisional
restoration was inserted during the healing period. Pa-
tients were instructed to rinse with 0.12% chlorhexidine
solution twice a day until suture removal has taken
place after 7-10 days. Moreover, patients were
instructed to avoid any physical activity that will
abruptly raise or lower pressure in the sinus cavity as
well as avoiding vigorous mouth rinsing, smoking, and
touching the gums for at least 10 days following sur-
gery. Postoperative analgesic was prescribed involving
400 mg ibuprofen, 1 tablet 3 times daily and 500mg
paracetamol, 2 tablets 4 times per day, as long as re-
quired. All patients were prescribed postoperative anti-
biotics involving 800 mg phenoxymethylpenicillin
(Primcillin, Meda, Denmark), 2 tablets 3 times daily for
7 days. In case of penicillin allergy, 300 mg clindamy-
cin, 1 tablet 3 times daily for 7 days was used.
Fig. 1 An watertight adaptor with a tube was inserted in the prepared implant bed and connected to a syringe containing physiological saline
solution. The Schneiderian membrane was safely elevated by controlling the pressure of saline by means of the attached Physiolifter device
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Patient’s perception of recovery and patient-reported
outcome measures
Oral Health Impact Profile-14 (OHIP-14) was used to
assess OHRQL at enrollment. OHIP-14 is organized into
seven conceptual dimensions including functional limi-
tation, physical discomfort, psychological discomfort,
physical disability, psychological disability, social disabil-
ity, and handicap [14–16]. Two items are used to meas-
ure each dimension and consequently the questionnaire
consists of 14 items. Response format of OHIP-14 was
as follows: Very often = 4; fairly often or many times =
3; occasionally = 2; hardly ever or nearly never = 1;
never/I do not know = 0. The OHIP-14 scale ranged
from 0 to 56 and dimension score ranged from 0 to 8.
The values of the 14 items and each dimension were
summed to calculate the OHIP-14 severity score, with
higher scores indicating poorer OHRQL.
Patient’s perception of recovery including pain, oral
function impairments, general activity, and other symp-
toms was assessed after 1 week. A self-administrated
questionnaire examined social isolation, working isola-
tion, physical appearance, and mean duration of the
quality of life alterations as well as questions whether
they would undergo similar treatment again, if needed
or if they would recommend this treatment to a friend
or a relative, if indicated. Response format was yes or
no. Eating ability and diet variations, speaking ability no-
ticed, sleep impairment, and pain and discomfort at su-
ture removal were also examined through self-
administrated questionnaire after 1 week. Each item was
evaluated by means of a four-point Likert-type rating
scale. Response format was as follows: Not at all = 0;
close to normal = 1; almost normal = 2; a little = 3. The
rating score was calculated, with higher score indicating
poorer patient recovery. Self-administrated questionnaire
also examined how many days they have been on sick
leave or been off work, had eating and speech difficul-
ties, and how long their sleep and physical activity have
been affected.
Patient’s perception of recovery was also examined by
a self-administrated questionnaire after 1 month and
supplemented by a 100 mm (0 = minimal to 100 = max-
imum) visual analog scale (VAS) assessing pain, social
isolation, working isolation, eating ability, speaking abil-
ity, and sleep impairment.
Instructions for completing OHIP-14, self-administrated
questionnaires and VAS were explained in detail to the
patients. Patients completed the questionnaires by them-
selves, to prevent being influenced by the surgeons or
nurses’ opinions and wills. Moreover, in order not to influ-
ence the compilation of the questionnaire, patients were
not informed about their allocation group.
Intra-operative and postoperative complications in-
cluding infection, wound dehiscence, nasal bleeding, ex-
plantation of implant or grafting material, exfoliation of
grafting material or adverse events were also registered.
Correlation of patient’s perception of recovery and oral
health-related quality of life
Impaired OHRQL, gender, and age at enrollment were
correlated to self-administrated questionnaires assessing
patient’s perception of recovery after 1 week and 1
month. OHIP-14 item score of 10 or more was consid-
ered as impaired preoperative OHRQL.
Statistical analyses
Data management and analysis was conducted using
STATA (Data analysis and statistical software, version
16, StataCorp P, Texas, USA). Mean and standard devia-
tions were reported when variables were considered
Table 2 Demographic characteristics of included patients
OMSFE with Bio-Oss collagen OMSFE without grafting material P value
Gender (male/female) 3/17 10/10 0.04*
Age at the time of OMSFE, mean (SD) 50.2 year (SD: 14.2) 48.1 year (SD: 9.1) 0.59
Smoking habits 0 1 1.00
Residual alveolar bone height (mm) at implant site, mean (SD) 6.8 (0.9) 7.2 (1.1) 0.36
Width of the alveolar ridge (mm) at implant site, mean (SD) 9.1 (0.6) 9.1 (0.8) 0.82
Implant location (second premolar) 9 5
Implant location (first molar) 11 12
Implant location (second molar) 0 3
Number of implants with 3.6 mm diameter 1 0
Number of implants with 4.2 mm diameter 7 5
Number of implants with 4.8 mm Diameter 12 15
Implant surface protruding into the sinus (mm), mean (SD) 6.2 (0.9) 5.9 (1.1) 0.18
OMSFE Osteotome-mediated sinus floor elevation; SD Standard deviation
*Statistically significant
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continuous, e.g., scores and Likert scales. Comparisons
for continuous variables were made by t test on the
mean difference. Categorical variables were reported by
counts and percentages. Dependencies for binary vari-
ables were tested by Fisher’s exact test. Dependencies for
non-binary categorical were tested by chi-squared test of
independence. Level of significance was 0.05. Sub-
analysis where performed to analyze whether OHIP-14
levels were significantly different within each of the
treatment modalities.
Results
Forty patients underwent OMSFE with simultaneous
implant placement. Patient characteristics are outlined
in Table 2. There were no significant differences in
distribution according to age, smokers and non-
smokers, implant location, residual alveolar bone
height, and width of the alveolar process. Significantly
more females were included and allocated to OMSFE
with Bio-Oss collagen (P=0.04). A minor perforation
of the Schneiderian membrane was observed in one
patient receiving OMSFE without a grafting material.
Healing was uneventful in all patients and none of
the included patients needed additional prescription
of analgesics or antibiotic. No implant losses or graft
infections were observed, but five patients described
minor epistaxis during the first postoperative days.
All patients attended postsurgical examinations and
Table 3 Percentage distribution of responses to each question of OHIP-14 questionnaire
Question OMSFE with Bio-Oss collagen OMSFE without grafting
material
0 1 2 3 4 Mean 0 1 2 3 4 Mean
Functional
limitation
Have you had trouble pronouncing any words
because of problems with your teeth, mouth,
or dentures?
95% 5% 0.05 90% 10% 0.1
Have you felt that your sense of taste has worsened
because of problems with your teeth, mouth, or
dentures?
100% 0 95% 5% 0.05
Physical pain Have you had painful aching in your mouth? 45% 45% 10% 0.65 55% 25% 15% 5% 0.7
Have you found it uncomfortable to eat any foods
because of problems with your teeth, mouth, or
dentures?
50% 25% 20% 5% 0.8 45% 35% 15% 5% 0.8
Psychological
discomfort
Have you been self-conscious because of your teeth,
mouth, or dentures?
30% 20% 35% 10% 5% 1.4 50% 15% 30% 5% 0.9
Have you felt tense because of problems with your teeth,
mouth, or dentures?
55% 5% 30% 10% 0.95 65% 15% 5% 0.55
Physical
disability
Has your diet been unsatisfactory because of problems with
your teeth, mouth, or dentures?
80% 10% 10% 0.3 80% 15% 5% 0.25
Have you had to interrupt meals because of problems with
your teeth, mouth, or dentures?
70% 25% 5% 0.35 80% 15% 5% 0.25
Psychological
disability
Have you found it difficult to relax because of problems with
your teeth, mouth, or dentures?
75% 5% 20% 0.45 65% 20% 10% 5% 0.65
Have you been a bit embarrassed because of problems with
your teeth, mouth, or dentures?
35% 10% 25% 30% 1.5 50% 20% 30% 0.8
Social
disability
Have you been a bit irritable with other people because of
problems with your teeth, mouth, or dentures?
85% 5% 10% 0.25 85% 5% 10% 0.25
Have you had difficulty doing your usual jobs because of
problems with your teeth, mouth, or dentures?
95% 5% 0.1 90% 10% 0.1
Handicap Have you felt that life in general was less satisfying
because of problems with your teeth, mouth,
or dentures?
55% 25% 15% 5% 0.7 75% 15% 10% 0.35
Have you been totally unable to function because of
problems with your teeth, mouth, or dentures?
95% 5% 0.2 95% 5% 0.2
Total OHIP-14 score: 152
Mean OHIP-14 score for each pa-
tient: 7.7
Mean OHIP-14 score for all items:
0.6 (SD: 0.5)
Total OHIP-14 score: 109
Mean OHIP-14 score for each
patient: 6.0
Mean OHIP-14 score for all
items: 0.4 (SD: 0.3)
OMSFE Osteotome-mediated sinus floor elevation
0 = never; 1 = hardly ever or nearly never; 2 = occasionally; 3 = fairly often or many times; 4 = very often
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completed OHIP-14, self-administrated questionnaires,
and VAS.
Mean OHIP-14 and dimension score was 7.6 (SD:
9.5) and 0.6 (SD: 0.5) for OMSFE with Bio-Oss colla-
gen compared with 6.0 (SD: 5.9) and 0.4 (SD: 0.3)
without a grafting material, respectively, indicating no
differences in OHRQL between the two groups (Table
3) (Figs. 2 and 3). Psychological discomfort and dis-
ability presented highest OHIP-14 dimension score,
while functional limitation exhibited the lowest score
indicating that self-consciousness, tension, and embar-
rassment were the factors which were significantly af-
fected in both groups.
Questionnaire after 1 week revealed minor influence
on patient’s daily life activities with both treatment mo-
dalities (Tables 4 and 5). All patients were satisfied with
the treatment and would recommend it to friends and
relatives (Table 4). However, number of days with eating
difficulties and sleep disturbances were significantly in-
creased after OMSFE with Bio-Oss collagen compared
with no grafting material (P=0.04, P=0.02) (Table 6).
Questionnaire after 1 month showed fast recovery with
both treatment modalities (Table 7). However, the num-
ber of days with pain and sleep disturbances was signifi-
cantly increased after OMSFE with Bio-Oss collagen
compared with no grafting material (P=0.02).
There was no statistically significant correlation be-
tween impaired OHRQL (OHIP-14 score ≥10) at enrol-
ment and patient’s perception of recovery after 1 week
and 1 month (Table 8). Moreover, gender and younger
age were generally not associated with impaired recov-
ery. Though, males indicated significantly greater eating
difficulties compared with females (P=0.03).
Discussion
The present study demonstrates no significant differ-
ences in patient’s perception of recovery and OHRQL
after OMSFE with Bio-Oss collagen compared with no
grafting material as evaluated by OHIP-14, self-
administrated questionnaires, and VAS. High patient
satisfaction, minimal discomfort, willingness to undergo
the same type of surgery, and low frequency of intra-
and postoperative complications was observed with both
treatment modalities. The influence on daily life activ-
ities including pain, minor swelling, and sick leave from
work seems to be minimal and limited to the first post-
operative days and most patients managed to return to
work and their routine daily activities after 0-2 days.
There were no obvious differences in social and working
isolation, physical appearance, quality of life alterations,
speaking ability, and discomfort between the two treat-
ment modalities. However, the number of days with
Fig. 2 OHIP-14 subscale dimension score after OMSFE with Bio-Oss collagen
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Table 4 Questionnaire assessing social and working isolation, physical appearance and quality of life alterations, at one week.
Question OMSFE with Bio-Oss collagen OMSFE without grafting material
Yes No Yes No
Social isolation
Did you keep your usual social activities? 95% 5% 100% 0%
Have you continued practicing your favorite sport or hobbies? 85% 15% 85% 15%
Working isolation
Did you ask for sick leave or discontinue your work? 25% 75% 20% 80%
Did the surgery affect your performance at work? 10% 90% 5% 95%
Did anyone accompany you or drive you to work due to surgery? 0% 100% 0% 100%
Has this person discontinued his/her work to do so? 10% 90% 0% 100%
Did somebody accompany you for suture removal? 10% 90% 5% 95%
Physical appearance
Have you noticed changes in your physical appearance? 25% 75% 15% 85%
Is it what you expected? 85% 15% 90% 10%
Has it been worse than expected? 15% 85% 5% 95%
Has it been better than expected? 80% 20% 95% 5%
Mean duration of the quality of life alterations
Are you satisfied with the treatment? 100% 0% 100% 0%
Would you recommend it? 100% 0% 100% 0%
Would you repeat it? 95% 5% 100% 0%
OMSFE Osteotome-mediated sinus floor elevation
Fig. 3 OHIP-14 subscale dimension score after OMSFE without a grafting material
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pain, eating difficulties and sleep disturbances was sig-
nificantly increased after OMSFE with Bio-Oss collagen
compared with no grafting material, although the differ-
ence seems to have limited clinical relevance.
The present study is characterized by following limita-
tions including small patient sample, solely collecting
postsurgical information corresponding to 1 week and 1
month, few self-administrated questionnaires, and no
registration of quantity and period of need for analgesics
after OMSFE. Moreover, association between socioeco-
nomic status, educational background, monthly income,
level of daily physical functioning, and patient’s percep-
tion of recovery was not examined. Conclusions drawn
from the results of this study should therefore be inter-
preted with caution.
OHRQL questionnaires provide valid and reliable in-
formation about the efficiency of treatment methods as
well as physical, psychological, and social consequences
for patients with different health states. OHIP-14 and
OHIP-49 are the most commonly used questionnaire de-
signed to measure impairment of OHRQL and patient’s
perception of the social impact of oral disorders on their
well-being [15, 16]. However, OHIP states the patient’s
overall oral impairment, and does not take a specific sur-
gical intervention into account. Consequently, OHIP is
frequently used in combination with additional OHRQL
questionnaires to interpret patient’s perception of a spe-
cified treatment modality and recovery.
Patient-related predictors for delayed clinical recovery
have important clinical implications for the decision-
Table 5 Questionnaire assessing eating and speaking ability, diet variations, sleep impairment, pain, and discomfort at 1 week
Question OMSFE with Bio-Oss collagen OMSFE without grafting material
0 1 2 3 0 1 2 3
Eating ability and diet variations
Did you continue with your usual diet? 80% 5% 15% 75% 20% 5%
Did you notice any change in the perception of taste? 75% 20% 5% 80% 20%
Did you notice any change in chewing ability? 35% 20% 5% 40% 55% 15% 30%
Did you have problems opening your mouth? 70% 15% 5% 10% 75% 15% 10%
Speaking ability noticed
Have you notice any change in voice? 80% 15% 5% 90% 10%
Have you notice any change in your ability to speak? 75% 20% 5% 90% 10%
When you talk with other people, do they understand you? 15% 85% 5% 95%
Sleep impairment
Have you had problems falling sleep? 65% 20% 5% 10% 75% 25%
Have you experienced interruptions in sleep? 60% 15% 25% 85% 15%
Have you felt drowsy? 15% 75% 5% 5% 100%
Pain and discomfort at suture removal
Has the removal of suture been uncomfortable? 95% 5% 75% 15% 10%
Has the appointment for suture removal caused you anxiety? 90% 5% 5% 70% 10% 5% 15%
OMSFE Osteotome-mediated sinus floor elevation
0 = not at all; 1 = close to normal; 2 = almost normal; 3 = a little
Table 6 Questionnaire assessing days of recovery at 1 week
Question OMSFE with Bio-Oss collagen OMSFE without grafting material P
valueMean (range), SD Mean (range), SD
How many days have you been on sick leave or been off work? 0.6 (0-3), 1.0 0.3 (0-2), 0.6 0.19
How many days have you had eating difficulties? 2.1 (0-10), 2.7 0.7 (0-5), 1.2 0.04*
How many days have you had speech difficulties? 0.5 (0-7), 1.6 0.0 (0-0), 0.0 0.17
How many days has your sleep been affected? 1.0 (0-6), 1.9 0.0 (0-0), 0.0 0.02*
How many days has your physical activity been affected? 1.1 (0-4), 1.6 1.1 (0-14), 3.2 1.00
OMSFE Osteotome-mediated sinus floor elevation
*Statistically significant
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Table 7 Questionnaire assessing pain, sick leave, performance, ability to eat, sleep, and speak at 1 month






Mean (range), SD Mean (range), SD
In how many days have you had pain after surgery? 3.2 (0-14), 3.3 1.3 (0-5), 1.3 0.02*
In how many days have you been on sick leave from daily activities such as work,
school, etc. due to pain?
0.7 (0-5), 1.3 0.2 (0-5), 0.5 0.16
Did the operation affect your performance of your daily work? (VAS: 0-100) 19.9 (0-100), 34.2 8.1 (0-73), 18.0 0.18
In how many days have you been affected in your work? 0.9 (0-5), 1.4 0.3 (0-2), 0.6 0.07
Have you been able to eat a normal diet in the post-operative period? (VAS: 0-100) 68 (6-100), 35.2 84.2 (5-100), 26.2 0.11
In how many days have you been unable to eat your normal diet? 1.4 (0-5), 1.5 1.1 (0-5), 1.3 0.45
Have you noticed changes in your speech after surgery? (VAS: 0-100) 4.7 (0-48), 12.0 0.9 (0-6), 1.8 0.17
In how many days have you noticed changes in your speech? 0.6 (0-7), 1.6 0.0 (0-0), 0.0 0.11
Have you had trouble sleeping at night after surgery? (VAS: 0-100) 11.8 (0-100), 30.1 0.8 (0-6), 1.7 0.11
In how many days have your night’s sleep been affected? 0.9 (0-5), 1.7 0.0 (0-0), 0.0 0.02*
OMSFE Osteotome-mediated sinus floor elevation; SD standard deviation; VAS visual analog scale (0 = minimal to 100 = maximum)
*Statistically significant
Table 8 Correlation between OHIP-14 item score at enrolment and patient’s perception of recovery after osteotome-mediated sinus
floor evaluation



























How many days have you been on sick leave or been off work? 0.4 (0.9) 1.2 (1.2) 0.11 0.2 (0.6) 0.4 (0.5) 0.50
How many days have you had eating difficulties? 1.9 (2.0) 2.7 (4.1) 0.55 0.8 (1.4) 0.4 (0.5) 0.54
How many days have you had speech difficulties? 0.7 (1.9) 0.0 (0.0) 0.38 0.0 (0.0) 0.0 (0.0)
How many days has your sleep been affected? 1.1 (2.1) 0.7 (1.2) 0.62 0.0 (0.0) 0.0 (0.0)
How many days has your physical activity been affected? 1.2 (1.8) 0.7 (1.2) 0.50 1.4 (3.6) 0.0 (0.0) 0.41
Month
How many days have you had pain after surgery? 2.9 (3.8) 3.8 (1.5) 0.59 1.3 (1.5) 1.0 (0.7) 0.64
In how many days have you been on sick leave from daily activities? 0.5 (1.4) 1.0 (1.1) 0.45 0.1 (0.5) 0.4 (0.5) 0.34
Did the operation affect your performance of your daily work? (VAS) 14.3 (33.9) 33.0 (33.9) 0.27 9.7 (20.6) 3.4 (3.7) 0.51
In how many days have you been affected in your work? 0.6 (1.4) 1.5 (1.4) 0.23 0.2 (0.6) 0.4 (0.5) 0.50
In how many days have you been unable to eat your normal diet? 1.6 (1.4) 1.2 (1.9) 0.60 1.3 (1.5) 0.6 (0.5) 0.35
Have you been able to eat a normal diet in the post-operative period?
(VAS)
59.1 (38.0) 89.0 (14.1) 0.08 86.9 (21.1) 76.2 (40.0) 0.45
Have you noticed changes in your speech after surgery? (VAS) 6.4 (14.2) 0.7 (0.8) 0.34 0.7 (1.7) 1.6 (2.3) 0.34
In how many days have you noticed changes in your speech? 0.9 (1.9) 0.0 (0.0) 0.29 0.0 (0.0) 0.0 (0.0)
Have you had trouble sleeping at night after surgery? (VAS) 15.2 (35.5) 4.0 (7.1) 0.46 0.5 (1.2) 1.8 (2.7) 0.15
In how many days have your night's sleep been affected? 1.0 (1.8) 0.7 (1.2) 0.69 0.0 (0.0) 0.0 (0.0)
OMSFE Osteotome-mediated sinus floor elevation; SD Standard deviation; VAS Visual analog scale (0 = minimal to 100 = maximum)
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making process before initiating prosthetic rehabilitation
of the atrophic posterior maxilla with implants. A previ-
ous study assessing patient perception of recovery after
maxillary sinus floor augmentation concluded that fe-
male and younger age were patient-related predictors for
delayed recovery [13]. In the present study, preoperative
OHIP-14 questionnaire was combined with self-
administrated questionnaires to assess patient’s percep-
tion of recovery after OMSFE disclosing no correlation
between impaired preoperative OHRQL and worsened
perception of recovery. Moreover, no association be-
tween gender or younger age and impaired recovery
were identified.
OHRQL and PROM reflects psychosocial parameters
related to patient’s perception of the surgical interven-
tion and recovery including pain, swelling, discomfort
when eating, sleeping, working, and social interaction as
well as their self-esteem and satisfaction with their oral
health. However, OHRQL and patient’s subjective as-
sessment of the treatment and recovery after OMSFE is
seldom reported [9–12]. A previous study assessing pa-
tient’s perception of the surgical procedure after OMSFE
with or without a grafting material revealed that more
than 90% of the patients were satisfied with the implant
therapy and would undergo similar therapy again if ne-
cessary as well as recommend the treatment to a friend
or relative, if indicated [9]. However, approximately 23%
of the patients found the surgical experience unpleasant
and 5% of the patients experienced vertigo, nausea, and
felt disoriented after OMSFE. Moreover, five patients ex-
perienced psychological problems, which needed medical
assistance [9]. In the present study, all patients were sat-
isfied with the implant therapy and would recommend
the treatment to a friend or relative. Only one patient
would not undergo similar therapy again. None of the
patients reported disorientation, nausea, or vertigo after
OMSFE, but discomfort during osteotome hammering
was frequently described. Benign paroxysmal positional
vertigo has previously been reported after OMSFE with
osteotome hammering due to detachment of otoliths
from the otoconia layer of the utricular macula [17–19].
Although OMSFE induced benign paroxysmal positional
vertigo is rare, the experience of postoperative disorien-
tation and vertigo will certainly affect patient’s percep-
tion of recovery.
Patient preferences have previously been assessed after
OMSFE with Cosci technique using a series of atrau-
matic lifting drills compared with Summers’ technique
including flat-tipped osteotomes [10]. No discomfort or
complications was reported after Cosci technique,
whereas postoperative swelling or headache was de-
scribed in 80% of the patients with the Summers’ tech-
nique [10]. In the present study, sinus membrane
elevation was performed with Summers’ technique in
combination with hydraulic technique. None of the pa-
tients complained of postoperative headache. Previous
studies assessing OMSFE with hydraulic pressure and vi-
brations have demonstrated high implant survival rate,
limited peri-implant marginal bone loss, and minimal
patient discomfort [20–22]. Moreover, no pain was re-
ported in 67% of the patients and 56% experienced no
swelling after hydraulic OMSFE [22].
PROM after OMSFE with simultaneous implant place-
ment compared with implant placement in native bone
have demonstrated no significant difference in discom-
fort, willingness to undergo the same type of surgery,
pain, and use of postoperative analgesics [11]. Both
treatment modalities revealed low postoperative pain
and medication [11]. These results are in agreement with
the present study.
OMSFE with simultaneous implant placement has
demonstrated a significant higher level of pain score
compared with maxillary sinus floor augmentation on
the day of surgery [12]. Level of pain was assessed by
VAS revealing a significant decreased in pain from the
first postoperative day with both treatment modalities.
OMSFE was characterized by significantly lower inci-
dence of swelling, bruising, and nasal discharge/bleeding
as well as less severe limitation in swallowing, continuing
daily activities, eating, speaking, opening the mouth, and
going to school/work compared with maxillary sinus
floor augmentation [12]. In the present study, most pa-
tients reported only minor pain during the first postop-
erative day and minimal swelling and discomfort.
Schneiderian membrane perforation is the most fre-
quent intraoperative complication after OMSFE, with
prevalence up to 40% [1–3, 23]. Perforation of the
Schneiderian membrane may result in communication
and displacement of grafting material into the maxillary
sinus. Previous studies assessing Schneiderian membrane
perforation after OMSFE using ultrasonic piezoelectric
vibration and hydraulic pressure have reported an inci-
dence of 3-9% [20, 24]. In the present study, Schneider-
ian membrane perforation occurred 2.5%. Perforation of
the Schneiderian membrane after OMSFE may not ne-
cessarily influence patient’s perception of recovery but
increase the probability of postoperative infection, sinus-
itis, and subsequently failure of the implant [25].
Conclusions
Within the limitations of the present study, it can be
concluded that OMSFE with Bio-Oss collagen compared
with no grafting material is associated with high patient
satisfaction, minimal discomfort, willingness to undergo
the same type of surgery, and low frequency of intra-
and postoperative complications. The present study
demonstrates that 2-3 days of recovery from OMSFE is
usually needed for patients to resume oral function and
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daily activities without limitations or need for analgesics.
Moreover, impaired preoperative oral health-related
quality of life, gender, or younger age seems not to pre-
dispose for delayed recovery.
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